HUP9904485A3 - Lowering blood levels of lipoprotein (a) - Google Patents

Lowering blood levels of lipoprotein (a)

Info

Publication number
HUP9904485A3
HUP9904485A3 HU9904485A HUP9904485A HUP9904485A3 HU P9904485 A3 HUP9904485 A3 HU P9904485A3 HU 9904485 A HU9904485 A HU 9904485A HU P9904485 A HUP9904485 A HU P9904485A HU P9904485 A3 HUP9904485 A3 HU P9904485A3
Authority
HU
Hungary
Prior art keywords
lipoprotein
blood levels
lowering blood
lowering
levels
Prior art date
Application number
HU9904485A
Other languages
Hungarian (hu)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU9904485D0 publication Critical patent/HU9904485D0/en
Publication of HUP9904485A2 publication Critical patent/HUP9904485A2/en
Publication of HUP9904485A3 publication Critical patent/HUP9904485A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
HU9904485A 1998-12-04 1999-12-03 Lowering blood levels of lipoprotein (a) HUP9904485A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11110098P 1998-12-04 1998-12-04

Publications (3)

Publication Number Publication Date
HU9904485D0 HU9904485D0 (en) 2000-02-28
HUP9904485A2 HUP9904485A2 (en) 2000-08-28
HUP9904485A3 true HUP9904485A3 (en) 2000-09-28

Family

ID=22336605

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904485A HUP9904485A3 (en) 1998-12-04 1999-12-03 Lowering blood levels of lipoprotein (a)

Country Status (6)

Country Link
JP (1) JP2000169395A (en)
KR (1) KR20000047857A (en)
CA (1) CA2291471A1 (en)
HU (1) HUP9904485A3 (en)
IL (1) IL133201A0 (en)
ZA (1) ZA997446B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324801A1 (en) * 1999-11-10 2001-05-10 Andrew Gordon Swick Use of apo b secretion/mtp inhibitors and anti-obesity agents
IL139450A0 (en) * 1999-11-10 2001-11-25 Pfizer Prod Inc Methods of administering apo b-secretion/mtp inhibitors
IL139449A0 (en) * 1999-11-10 2001-11-25 Pfizer Prod Inc Use of apo b secretion/mtp inhibitors
CA2324800A1 (en) * 1999-11-10 2001-05-10 Mary Anne Hickman Use of apo b secretion/mtp inhibitors
US7625948B2 (en) 2002-02-28 2009-12-01 Japan Tobacco Inc. Ester compound and medicinal use thereof
WO2005021486A1 (en) 2003-08-29 2005-03-10 Japan Tobacco Inc. Ester derivative and medicinal use thereof
JP5697296B2 (en) 2004-03-05 2015-04-08 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Method for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia with minimal side effects
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof

Also Published As

Publication number Publication date
CA2291471A1 (en) 2000-06-04
HUP9904485A2 (en) 2000-08-28
HU9904485D0 (en) 2000-02-28
ZA997446B (en) 2001-06-04
IL133201A0 (en) 2001-03-19
JP2000169395A (en) 2000-06-20
KR20000047857A (en) 2000-07-25

Similar Documents

Publication Publication Date Title
HUP0103526A3 (en) Catheter set
GB9703637D0 (en) Surgical instrumentation
AU1450900A (en) Methods of treatment of type 2 diabetes
AUPP713498A0 (en) A method of detecting blood
GB9811116D0 (en) Method of altering heartbeat
HU9904485D0 (en) Lowering blood levels of lipoprotein (a)
GB9802517D0 (en) Alterness monitor
EP1135119A4 (en) Glucose and lipid lowering compounds
GB9916051D0 (en) Insertable insole
GB9820804D0 (en) ANSI syringe
PL332879A1 (en) Method of obtaining biphenol a
GB9824518D0 (en) Patient movement aid
GB0009679D0 (en) Medical drainage apparatus
ZA991746B (en) Managing use of a medical aid scheme
AU142197S (en) Tissue
IL124294A0 (en) Physiological monitoring of a subject
GB9812314D0 (en) Treatment of diabetes
GB9815149D0 (en) Treatment of diabetes
GB9917285D0 (en) Medical apparatus
TW501487U (en) Novel structure of goggles
PL326133A1 (en) Method of obtaining biphenol a
TW344214U (en) Improved structure of a fryer
TW409704U (en) Structure of hermetic can
GB9817916D0 (en) Arterial cannula
TW435201U (en) Improved structure of stethoscope